The OriGAMI-4 trial reveals subcutaneous Rybrevant's 45% response rate in metastatic head and neck cancer patients after immunotherapy and platinum.
The company is pursuing a Phase 3 trial in its most exciting pipeline drug, and investors are awaiting potentially exciting ...
Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...
Independently developed by Junshi Biosciences, JS001sc injection is a subcutaneous injection based on the marketed product toripalimab injection (code: JS001) that is expected to enhance convenience ...
AbbVie Inc. (NYSE:ABBV) is one of the best undervalued stocks to invest in right now. AbbVie Inc. (NYSE:ABBV) announced on ...
What is the difference between visceral and subcutaneous fat Read ahead to know as an expert explains which type of belly fat ...
Viking is now looking forward to advancing the oral version of its experimental obesity drug into late-stage study in the third-quarter (Q3) of 2026. ・The subcutaneous formulation of the drug VK2735 ...
A subcutaneous version of the newly approved Alzheimer's drug lecanemab (Leqembi) may be on the horizon. Weekly subcutaneous lecanemab 100 mg/mL injection appeared to be as effective at amyloid plaque ...
Argenx has filed for FDA approval of subcutaneous efgartigimod, keeping it on track to start selling the sibling of its existing intravenous generalized myasthenia gravis (gMG) treatment Vyvgart. In ...
Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 SC amivantamab is now authorised across all ...
Nearly four years after the FDA rejected Takeda’s attempt to develop a subcutaneous formulation of blockbuster Entyvio (vedolizumab), the Japanese company has won the regulator over with its ...
A new study published in the journal of BMC Nephrology showed that subcutaneous and intravenous epoetin showed similar ...